FilingReader Intelligence
Shionogi expands pharma reach with JT business, Torii stake
May 7, 2025 at 12:01 PM UTC•By FilingReader AI
Shionogi & Co. ($TSE:4507) announced a series of strategic moves to bolster its pharmaceutical business, including an agreement to acquire Japan Tobacco Inc.’s (JT) pharmaceutical operations through a simplified absorption-type company split, and a tender offer to acquire all outstanding shares of Torii Pharmaceutical Co., Ltd. (TSE:4551) not already owned by JT. Shionogi is offering JPY 6,350 per Torii share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Notice Concerning Commencement of Tender Offer for Torii Pharmaceutical Co., Ltd. Shares (Stock Code: 4551)May 7, 2025 at 06:33 AM UTC
Notice of Commencement of Tender Offer for Shares of TORII PHARMACEUTICAL CO., LTD. (Securities Code: 4551)May 7, 2025 at 10:10 AM UTC
Notice of the Execution of an Agreement for Company Split (Simplified Absorption-type Split) of the Pharmaceutical Business of Japan Tobacco Inc. andMay 7, 2025 at 10:51 AM UTC
TSE:4507•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Shionogi & publishes news
Free account required • Unsubscribe anytime